[1]
“The influence of folate pathway polymorphisms on pemetrexed treatment outcome in patients with malignant mesothelioma”, Radiol Oncol, vol. 48, no. 2, May 2014, Accessed: Oct. 19, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/2043